Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000293889 is annotated as a long non-coding RNA (lncRNA) transcribed antisense to the INPP5A gene. Antisense lncRNAs are a class of RNA molecules that, while not coding for protein, can regulate the expression or processing of genes located on the opposite DNA strand, frequently influencing the chromatin state, mRNA stability, or translation of the corresponding sense gene[3]. The specific functional role of this novel transcript is currently uncharacterized. Similar antisense lncRNAs are broadly implicated in gene regulation, but there is no direct evidence for therapeutic targeting, clinical association, or interacting drugs with this transcript at this time[3][4]. The presence of an annotated antisense transcript at this locus is consistent with widespread patterns of pervasive transcription and regulation observed in mammalian genomes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to INPP5A (ENSG00000293889).